Tower Research Capital LLC (Trc) Denali Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 431 shares of DNLI stock, worth $10,421. This represents 0.0% of its overall portfolio holdings.

Number of Shares

431

Previous 20,832 97.93%

Holding current value

$10,421

Previous $483,000 97.52%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$20.96 - $31.05 $427,604 - $633,451	-20,401 Reduced 97.93%	431 $12,000
Q2 2024 Aug 13, 2024	BUY	$14.96 - $23.22 $290,328 - $450,630	19,407 Added 1361.89%	20,832 $483,000
Q1 2024 May 15, 2024	SELL	$15.83 - $23.35 $68,053 - $100,381	-4,299 Reduced 75.1%	1,425 $29,000
Q4 2023 Feb 13, 2024	BUY	$16.2 - $23.18 $65,059 - $93,090	4,016 Added 235.13%	5,724 $122,000
Q3 2023 Nov 14, 2023	SELL	$20.63 - $30.17 $88,337 - $129,187	-4,282 Reduced 71.49%	1,708 $35,000
Q2 2023 Aug 14, 2023	BUY	$23.37 - $32.96 $46,389 - $65,425	1,985 Added 49.56%	5,990 $176,000
Q1 2023 May 09, 2023	BUY	$21.91 - $32.67 $53,701 - $80,074	2,451 Added 157.72%	4,005 $92,000
Q4 2022 Feb 10, 2023	SELL	$26.28 - $33.92 $332,757 - $429,495	-12,662 Reduced 89.07%	1,554 $44,000
Q3 2022 Nov 10, 2022	BUY	$25.97 - $38.53 $96,089 - $142,561	3,700 Added 35.18%	14,216 $437,000
Q2 2022 Aug 15, 2022	BUY	$20.88 - $35.19 $175,788 - $296,264	8,419 Added 401.48%	10,516 $309,000
Q1 2022 May 12, 2022	SELL	$29.0 - $47.27 $152,018 - $247,789	-5,242 Reduced 71.43%	2,097 $68,000
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $81,943 - $105,858	1,924 Added 35.53%	7,339 $328,000
Q3 2021 Nov 15, 2021	BUY	$48.48 - $78.23 $43,050 - $69,468	888 Added 19.62%	5,415 $273,000
Q2 2021 Aug 16, 2021	SELL	$50.3 - $78.44 $157,690 - $245,909	-3,135 Reduced 40.92%	4,527 $355,000
Q1 2021 May 17, 2021	BUY	$53.8 - $81.53 $195,025 - $295,546	3,625 Added 89.79%	7,662 $437,000
Q4 2020 Feb 16, 2021	BUY	$36.89 - $93.56 $63,856 - $161,952	1,731 Added 75.07%	4,037 $338,000
Q3 2020 Nov 16, 2020	SELL	$23.13 - $38.84 $168,270 - $282,561	-7,275 Reduced 75.93%	2,306 $83,000
Q2 2020 Aug 13, 2020	BUY	$16.01 - $28.82 $153,391 - $276,124	9,581 New	9,581 $232,000
Q4 2019 Feb 07, 2020	SELL	$14.4 - $19.99 $30,168 - $41,879	-2,095 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$15.32 - $21.92 $30,333 - $43,401	1,980 Added 1721.74%	2,095 $32,000
Q2 2019 Aug 13, 2019	SELL	$18.5 - $28.14 $13,190 - $20,063	-713 Reduced 86.11%	115 $2,000
Q1 2019 May 14, 2019	BUY	$17.99 - $24.65 $12,970 - $17,772	721 Added 673.83%	828 $19,000
Q4 2018 Feb 14, 2019	BUY	$13.88 - $21.75 $1,485 - $2,327	107 New	107 $2,000
Q3 2018 Nov 13, 2018	SELL	$12.46 - $21.74 $45,703 - $79,742	-3,668 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$15.25 - $21.02 $55,937 - $77,101	3,668 New	3,668 $56,000

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.24B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Denali Therapeutics Inc. Transaction History